InvestorsHub Logo
Followers 0
Posts 82
Boards Moderated 0
Alias Born 01/15/2010

Re: None

Wednesday, 01/27/2010 3:48:34 PM

Wednesday, January 27, 2010 3:48:34 PM

Post# of 44155
Bederra Corporation (PINKSHEETS: BEDA), a Houston, Texas-based, diversified medical services provider, announced an update to shareholders with respect to management's expectations and plans for the company's growth in 2010.

The acquisition of Texas Mobile Health is progressing and now pends final documentation for completion. The acquisition is expected to add approximately $3-4 million in gross revenue per year. Upon completion of the acquisition, management intends to increase the availability and diversity of mobile services provided throughout 2010. Management will also explore further geographical markets for the company's mobile diagnostic division.

As stated in the company's original business plan, the company will attempt to acquire other diversified medical services that will expand the company's revenues. The company is currently evaluating an entry into pharmaceutical services provided to physicians. Management's interest in this area stems from the company's advantage of possessing a large physician referral base which it believes could translate into a large revenue stream for the company while further diversifying the company's revenue streams within the medical services industry.

A reopening of its Reliant Medical Group Clinic is a 2010 objective for the company and Reliant representatives are currently evaluating new locations and possible partners to enhance the clinic experience for clients and enhance the efficiency of the clinics.

The company plans to increase its transparency on pinksheets.com through the disclosure of further material information as soon as possible and by engaging an SEC attorney who specializes in Pink Sheet issues and compliance. Management believes the company will be a Pink Sheets "Current Issuer" in the first fiscal half of the new year.

Due to the company's due diligence, the acquisition of Neogenex Medical Technologies will not go forward at this time. The company has left open the possibility of a future acquisition of Neogenex should the impediments raised in due diligence be eliminated.

We would like to wish all of our shareholders a very Happy New Year and look forward to seeing enhanced shareholder value in 2010 and beyond.